For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world's deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.
Scope of the Report:
This report studies the TB Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the TB Diagnostic market by product type and applications/end industries.
The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test.
In base year 2017, laboratory methods are leading the types segment due to rising prevalence of tuberculosis, easy collection of specimen sample and available at low cost. Nucleic acid testing, cytokine detection test segment is anticipated to register faster growth in the test types segment throughout the forecast period 2017-2023, as it is providing greater accuracy and requires less incubation period for the interpretation of the results. In 2017 Asia Pacific region dominated the tuberculosis diagnostics market due to factors such as large patient pool suffering with tuberculosis, government and non-government initiatives to eradicate tuberculosis and high disposable income in these regions.
The global TB Diagnostic market is valued at 2040 million USD in 2017 and is expected to reach 2540 million USD by the end of 2023, growing at a CAGR of 3.7% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of TB Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Abbott Laboratories
- Becton Dickinson and Company
- F. Hoffman La Roche
- Hain Lifescience
- Hologic Corporation
- Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Radiographic Method
- Diagnostic Laboratory Methods
- Nucleic Acid Testing
- Phage Assay
- Detection of Latent Infection
- Cytokine Detection Assay
- Detection of Drug Resistance
Market Segment by Applications, can be divided into